Clinical trials recruiting in Loxahatchee Groves, Florida

Phase breakdown

Conditions recruiting in Loxahatchee Groves, Florida

Recruiting trials in Loxahatchee Groves, Florida

• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
  NCT04965675 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female)
• A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
  NCT05164172 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female)
• A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
  NCT07323654 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
  NCT07363694 · Phase: Phase 2, Phase 3 · Ages: 35 Years to 80 Years · Sex: All (male and female)
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
  NCT06959095 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
  NCT07190222 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
  NCT05669833 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Project: Every Child for Younger Patients With Cancer
  NCT02402244 · Phase: Not specified · Ages: Up to 25 Years · Sex: All (male and female)
• Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
  NCT04748601 · Phase: Phase 4 · Ages: 6 Years to 11 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Loxahatchee Groves, Florida?

10 recruiting trials have at least one study site in Loxahatchee Groves, Florida.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.